Predictive value of soluble intercellular adhesion molecule-1 for risk of ischemic events in individuals with cerebrovascular disease

Cerebrovascular Diseases

Volumn 20, Issue 6, 2005, Pages 456-462

  Ehrensperger, Eric ^a   Minuk, Jeffrey ^b   Durcan, Liam ^c   Mackey, Ariane ^e   Wolfson, Christina ^d   Fontaine, Anne Marie ^a   Côté, Robert ^a  

^a MONTREAL GENERAL HOSPITAL   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d MCGILL UNIVERSITY   (Canada)

^e LAVAL UNIVERSITY   (Canada)

Author keywords

Atherosclerosis; Carotid stenosis; Cellular adhesion molecules; Inflammation; Ischemic events

Indexed keywords

ACETYLSALICYLIC ACID; ANTIHYPERTENSIVE AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; HYPOCHOLESTEROLEMIC AGENT; INSULIN; INTERCELLULAR ADHESION MOLECULE 1; ORAL ANTIDIABETIC AGENT;

AGED; ARTICLE; CAROTID ARTERY OBSTRUCTION; CEREBROVASCULAR ACCIDENT; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETES MELLITUS; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; RISK FACTOR; TRANSIENT ISCHEMIC ATTACK;

AGED; BRAIN ISCHEMIA; CAROTID STENOSIS; CEREBROVASCULAR DISORDERS; ENDPOINT DETERMINATION; FEMALE; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; LOGISTIC MODELS; MALE; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 27944487853     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000088985     Document Type: Article

References (34)

1. Ross R: Atherosclerosis - an inflammatory disease. NEJM 1999;340:115-126.
2. Libby P, Ridker P, Maseri A: Inflammation and atherosclerosis. Circulation 2002;105:1135-1143.
3. DeGrabba TJ: The role of inflammation in atherosclerosis. Adv Neurol 2003;92:29-42.
4. Libby P: Inflammation in atherosclerosis. Nature 2002;420:868-874.
5. Price DT, Loscalzo J: Cellular adhesion molecules and atherogenesis. Am J Med 1999;107:85-97.
6. Gearing AJH, Newman W: Circulating adhesion molecules in disease. Immunol Today 1993;14:506-512.
7. Blankenberg S, Barbaux S, Tiret L: Adhesion molecules and atherosclerosis. Atherosclerosis 2003;170:191-203.
8. Hwang SJ, Ballantyne CM, Sharret AR, Smith LC, Davis CE, Gotto AM, Boerwinkle E: Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the atherosclerosis risk in communities (ARIC) study. Circulation 1997;96:4219-4225.
9. Blann AD, Amiral J, McCollum CN: Circulating endothelial cell/leukocyte adhesion molecules in ischaemic heart disease. Br J Haematol 1996;95:263-265.
10. Blann AD, Seigneur M, Steiner M, Miller JP, McCollum CN: Circulating ICAM-1 and VCAM-1 in peripheral artery disease and hypercholesterolemia: relationship to the location of atherosclerosis, smoking, and in the prediction of adverse events. Thromb Haemost 1998;79:1080-1085.
11. Fassbender K, Bersch T, Mielke O, Muhlhauser F, Hennerici M: Adhesion molecules in cerebrovascular diseases: evidence for an inflammatory endothelial activation in cerebral large- and small-vessel disease. Stroke 1999;30:1647-1650.
12. Ridker P, Hennekens CH, Roitman-Johnson B, Stampfer MJ, Allen J: Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men. Lancet 1998;351:88-92.
13. Haim M, Tanne D, Boyko V, Reshef T, Goldbourt U, Leor J, Mekori YA, Behar S: Soluble intercellular adhesion molecule-1 and long-term risk of acute coronary events in patients with chronic coronary heart disease. J Am Coll Cardiol 2002;39:1133-1138.
14. Tanne D, Haim M, Boyko V, Goldbourt U, Reskef T, Matetzky S, Adler Y, Mekori YA, Behar S: Soluble intercellular adhesion molecule-1 and risk of future ischemic stroke. Stroke 2002;33:2182-2186.
15. DeGrabba TJ, Sirén AL, Penix LR, McCarron RM, Margraves R, Sood S, Pettigrew KD, Hallenbeck JM: Increased endothelial expression of intercellular adhesion molecule-1 in symptomatic versus asymptomatic human carotid atherosclerotic plaque. Stroke 1998;29:1405-1410.
16. Nuotio K, Lindsberg PJ, Carpén O, Soinne L, Lehtonen-Smeds EMP, Saimanen E, Lassila T, Sairanen T, Sarna S, Salonen O, Kovanen PT, Kaste M: Adhesion molecule expression in symptomatic and asymptomatic carotid stenosis. Neurology 2003;60:1890-1899.
17. Frijns CJM, Kappelle LJ, van Gijn J, Nieuwenhuis HK, Sixma JJ, Fijnheer R: Soluble adhesion molecules reflect endothelial cell activation in ischemic stroke and in carotid atherosclerosis. Stroke 1997;28:2214-2218.
18. Malik I, Danesh J, Whincup P, Bhatia V, Papacosta O, Walker M, Lennon L, Thomson A, Haskard D: Soluble adhesion molecules and prediction of coronary heart disease: a prospective study and meta-analysis. Lancet 2001;358:971-975.
19. Blann AD, McCollum CN: Circulating ICAM-1 in peripheral arterial disease as a predictor of adverse events. Lancet 1998;351:1135.
20. Roederer GO, Langlois YE, Jager KA, Primozich JF, Beach KW, Phillips DJ, Strandness DE Jr: The natural history of carotid arterial disease in asymptomatic patients with cervical bruits. Stroke 1984;15:614-621.
21. Ridker PM, Hennekens CH, Buring JE, Rifai N: C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. NEJM 2000;342:836-843.
22. Mulvihill NT, Foley JB, Crean P, Walsh M: Prediction of cardiovascular risk using soluble cell adhesion molecules. Eur Heart J 2002;23:1569-1574.
23. Rohde LE, Hennekens CH, Ridker PM: Cross-sectional study of soluble intercellular adhesion molecule-1 and cardiovascular risk factors in apparently healthy men. Arterioscler Thromb Vasc Biol 1999;1595-1599.
24. Bitsch A, Klene W, Murtada L, Prange H, Rieckmann P: A longitudinal prospective study of soluble adhesion molecules in acute stroke. Stroke 1998;29:2129-2135.
25. Shyu K-G, Chang H, Lin C-C: Serum levels of intercellular adhesion molecule-1 and E-selectin in patients with acute ischemic stroke. J Neurol 1997;224:90-93.
26. Mocco J, Tanvir F, Choudhri TF, Mack WJ, Laufer I, Lee J, Kiss S, Poisik A, Quest DO, Solomon RA, Connolly ES: Elevation of soluble intercellular adhesion molecule-1 levels in symptomatic and asymptomatic carotid atherosclerosis. Neurosurgery 2001;48:718-722.
27. Rohde LE, Lee RT, Rivero J, Jamacochian M, Arroyo LH, Briggs W, Rifai N, Libby P, Creager MA, Ridker PM: Circulating adhesion molecules are correlated with ultrasound-based assessment of carotid atherosclerosis. Arterioscler Thromb Vasc Biol 1998;18:1765-1770.
28. Okulla T, Gass S, Bohme K, Tiemann K, Harbrecht U, Klockgether T, Pohl C: Circulating adhesion molecules in patients with internal carotid artery stenosis. Cerebrovasc Dis 2002;14:9-14.
29. Fassbender K, Mossner R, Motsch L, Kischka U, Grau A, Hennerici M: Circulating selectin-and immunoglobulin-type adhesion molecules in acute ischemic stroke. Stroke 1995;26:1361-1364.
30. Blann AD, Farrell A, Picton A, McCollum CN: Relationship between endothelial cell markers and arterial stenosis in peripheral and carotid artery disease. Thromb Res 2000;97:209-216.
31. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH: Inflammation, aspirin and the risk of cardiovascular disease in apparently healthy men. NEJM 1997;336:973-979.
32. Blake GJ, Ridker PM: Are statins anti-inflammatory? Curr Control Trials Cardiovasc Med 2000;1:161-165.
33. Romano M, Mezzetti A, Marulli C, Ciabattoni G, Febe F, Di lenno S, Roccaforte S, Vigneri S, Nubile G, Milani M, Davi G: Fluvastatin reduces soluble P-selectin and ICAM-1 levels in hypercholesterolemic patients: role of nitric oxide: J Invest Med 2000;48:183-189.
34. Blake GJ, Ridker PM: Inflammatory biomarkers and cardiovascular risk prediction. J Intern Med 2002;252:282-294.